Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

Special cells can help regrow hair in alopecia areata.

People with alopecia areata are more likely to have other immune-related conditions.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

ILC1-like cells can independently cause alopecia areata.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

BST2 protein and certain T cells increase in early alopecia areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

A simple test can help diagnose a rare bruising disorder after ruling out other causes.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Certain genes are linked to the risk of developing Alopecia Areata.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Vitiligo and alopecia areata might be early signs of Type 1 Diabetes.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Arg1+ macrophages may play a role in causing alopecia areata.

Anti-keratin antibody from cow milk makes damaged hair stronger and less likely to break.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.